Literature DB >> 10182565

Biological products regulated under Section 351 of the Public Health Service Act; implementation of biologics license; elimination of establishment license and product license; public workshop--FDA. Proposed rule; notice of workshop.

.   

Abstract

The Food and Drug Administration (FDA) is announcing a public workshop to present issues related to the agency's proposed rule entitled "Biological Products Regulated Under Section 351 of the Public Health Service Act; Implementation of Biologics License; Elimination of Establishment License and Product License" issued recently in the Federal Register. The purpose of the public workshop is to provide interested persons an opportunity to more clearly understand the proposed rule and its effect on industry and the public.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10182565

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  1 in total

Review 1.  Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)-An Indian Perspective.

Authors:  Sathish Muthu; Madhan Jeyaraman; Moinuddin Basha Kotner; Naveen Jeyaraman; Ramya Lakshmi Rajendran; Shilpa Sharma; Manish Khanna; Sree Naga Sowndary Rajendran; Ji Min Oh; Prakash Gangadaran; Byeong-Cheol Ahn
Journal:  Bioengineering (Basel)       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.